Ryan S Robetorye Mayo Clinic Hospital, Phoenix, ArizonaTanzania
Commentry Next-Generation Sequencing (NGS)-Based Clinical Testing is Recommended for the Detection of Gene Mutations Associated with Familial Myelodysplastic Syndrome and Acute Myeloid Leukemia Predisposition Syndromes Author(s): Ryan S RobetoryeRyan S Robetorye
DOI: 10.4172/2469-9853.1000153
PDF